Advanced search
Publication Cover
Expert Review of Hematology Volume 13, 2020 - Issue 1
Submit an article Journal homepage
297
Views
6
CrossRef citations to date
0
Altmetric
Review

Minimizing and managing treatment-associated complications in patients with chronic lymphocytic leukemia

Elżbieta Iskierka-JażdżewskaDepartment of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, PolandView further author information
&
Tadeusz RobakDepartment of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, PolandCorrespondence[email protected]
View further author information
Pages 39-53 | Received 22 Jul 2019, Accepted 19 Nov 2019, Published online: 30 Nov 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Fernando Escalante Barrigón, Cristina Bas, Boxiong Tang, Keri Yang, Elisenda Pomares, Alejandra García & Nasim Bahar. (2023) Impact of atrial fibrillation in onco-hematological patients in Europe: a targeted literature review. Expert Review of Hematology 16:8, pages 617-627.
Read now
Elżbieta Iskierka-Jażdżewska & Tadeusz Robak. (2020) Investigational treatments for chronic lymphocytic leukemia: a focus on phase 1 and 2 clinical trials. Expert Opinion on Investigational Drugs 29:7, pages 709-722.
Read now

Articles from other publishers (4)

Piotr Smolewski & Tadeusz Robak. (2021) Der Stand der Therapie bei der refraktären/rezidivierenden chronischen lymphatischen Leukämie: Neuartige Wirkstoffe im Fokus. Kompass Onkologie 8:2, pages 59-69.
Crossref
Piotr Smolewski & Tadeusz Robak. (2021) Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs. Acta Haematologica 144:4, pages 365-379.
Crossref
Kirsten Fischer, Othman Al-Sawaf & Michael Hallek. (2020) Preventing and monitoring for tumor lysis syndrome and other toxicities of venetoclax during treatment of chronic lymphocytic leukemia. Hematology 2020:1, pages 357-362.
Crossref
Parathan Karunakaran. (2021) Drug Review: Ibrutinib. Indian Journal of Medical and Paediatric Oncology 41:03, pages 383-392.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.